1887

Chapter 52 : The and

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

The and , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH52-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH52-2.gif

Abstract:

The three families of bacteria described in this chapter share several common characteristics despite the phylogenetic distance between the group that includes and , from the , and the more distantly related in the class. All three genera are zoonotic bacteria with species capable of infecting both animals and humans and are fastidious with special growth requirements; many species among these three genera cause emerging infections in humans. The diversity of natural animal reservoirs for members of the genera and are just now becoming fully defined and appreciated and are likely all around us. spp. and spp. are well-established as agents that warrant special attention and focus because of their potential for misuse and intentional release in acts of bioterrorism or biowarfare. This chapter briefly summarizes our knowledge of the taxonomy, epidemiology, and pathobiology of these zoonotic bacteria and describes the immunologic and molecular tools for the laboratory diagnosis of infections caused by these microbes.

Citation: Litwin C, Anderson B, Tsolis R, Rasley A. 2016. The and , p 473-482. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch52
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Taxonomy of the major human pathogens in the families , , and . Additional spp. and spp. not shown here have also been associated with human disease but are not listed due to space constraints. Members of the and genera are , while members of the genus are .

Citation: Litwin C, Anderson B, Tsolis R, Rasley A. 2016. The and , p 473-482. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch52
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818722.ch52
1. Wattam AR, Foster JT, Mane SP, Beckstrom-Sternberg SM, Beckstrom-Sternberg JM, Dickerman AW, Keim P, Pearson T, Shukla M, Ward DV, Williams KP, Sobral BW, Tsolis RM, Whatmore AM, O'Callaghan D. 2014. Comparative phylogenomics and evolution of the brucellae: a path to virulence. J Bacteriol 196:920930.[CrossRef].[PubMed]
2. Whatmore AM. 2009. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol 9:11681184.[CrossRef].[PubMed]
3. Ficht T. 2010. Brucella taxonomy and evolution. Future Microbiol 5:859866.[CrossRef].[PubMed]
4. McCoy GW, Chapin CW. 1912. Further observations on a plague-like disease of rodents with a preliminary note on the causative agent, Bacterium tularense. J Infect Dis 10:6172.[CrossRef]
5. Busse HJ, Huber B, Anda P, Escudero R, Scholz HC, Seibold E, Splettstoesser WD, Kämpfer P. 2010. Objections to the transfer of Francisella novicida to the subspecies rank of Francisella tularensis: response to Johansson et al. Int J Syst Evol Microbiol 60:17181720.[CrossRef].[PubMed]
6. Foley JE, Nieto NC. 2010. Tularemia. Vet Microbiol 140:332338.[CrossRef].[PubMed]
7. Zangwill KM, Hamilton DH, Perkins BA, Regnery RL, Plikaytis BD, Hadler JL, Cartter ML, Wenger JD. 1993. Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med 329:813.[CrossRef].[PubMed]
8. Raoult D, Fournier PE, Drancourt M, Marrie TJ, Etienne J, Cosserat J, Cacoub P, Poinsignon Y, Leclercq P, Sefton AM. 1996. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 125:646652.[PubMed].[CrossRef]
9. Bechtol D, Carpenter LR, Mosites E, Smalley D, Dunn JR. 2011. Brucella melitensis infection following military duty in Iraq. Zoonoses Public Health 58:489492.[CrossRef].[PubMed]
10. Harding AL, Byers KB,. 2006. Epidemiology of laboratory-associated infections, p 5377. In Fleming DO, Hunt DL (ed), Biological Safety: Principles and Practices, 4th ed. ASM Press, Washington, DC.[CrossRef]
11. Anderson BE, Neuman MA. 1997. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev 10:203219.[PubMed]
12. Lucero NE, Corazza R, Almuzara MN, Reynes E, Escobar GI, Boeri E, Ayala SM. 2010. Human Brucella canis outbreak linked to infection in dogs. Epidemiol Infect 138:280285.[CrossRef].[PubMed]
13. Tarnvik A, Berglund L. 2003. Tularaemia. Eur Respir J 21:361373.[PubMed].[CrossRef]
14. Bergmans AM, Peeters MF, Schellekens JF, Vos MC, Sabbe LJ, Ossewaarde JM, Verbakel H, Hooft HJ, Schouls LM. 1997. Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay. J Clin Microbiol 35:19311937.[PubMed]
15. Regnery RL, Olson JG, Perkins BA, Bibb W. 1992. Serological response to “Rochalimaea henselae” antigen in suspected cat-scratch disease. Lancet 339:14431445.[PubMed].[CrossRef]
16. Conrad DA. 2001. Treatment of cat-scratch disease. Curr Opin Pediatr 13:5659.[PubMed].[CrossRef]
17. Vermeulen MJ, Verbakel H, Notermans DW, Reimerink JH, Peeters MF. 2010. Evaluation of sensitivity, specificity and cross-reactivity in Bartonella henselae serology. J Med Microbiol 59:743745.[CrossRef].[PubMed]
18. Tsuruoka K, Tsuneoka H, Kawano M, Yanagihara M, Nojima J, Tanaka T, Yamamoto M, Ichihara K. 2012. Evaluation of IgG ELISA using N-lauroyl-sarcosine-soluble proteins of Bartonella henselae for highly specific serodiagnosis of cat scratch disease. Diagn Microbiol Infect Dis 74:230235.[CrossRef].[PubMed]
19. Hoey JG, Valois-Cruz F, Goldenberg H, Voskoboynik Y, Pfiffner J, Tilton RC, Mordechai E, Adelson ME. 2009. Development of an immunoglobulin M capture-based enzyme-linked immunosorbent assay for diagnosis of acute infections with Bartonella henselae. Clin Vaccine Immunol 16:282284.[CrossRef].[PubMed]
20. Anderson B, Lu E, Jones D, Regnery R. 1995. Characterization of a 17-kilodalton antigen of Bartonella henselae reactive with sera from patients with cat scratch disease. J Clin Microbiol 33:23582365.[PubMed]
21. Loa CC, Mordechai E, Tilton RC, Adelson ME. 2006. Production of recombinant Bartonella henselae 17-kDa protein for antibody-capture enzyme-linked immunosorbent assay. Diagn Microbiol Infect Dis 55:17.[CrossRef].[PubMed]
22. Cooper MD, Hollingdale MR, Vinson JW, Costa J. 1976. A passive hemagglutination test for diagnosis of trench fever due to Rochalimaea quintana. J Infect Dis 134:605609.[PubMed].[CrossRef]
23. Pappalardo BL, Correa MT, York CC, Peat CY, Breitschwerdt EB. 1997. Epidemiologic evaluation of the risk factors associated with exposure and seroreactivity to Bartonella vinsonii in dogs. Am J Vet Res 58:467471.[PubMed]
24. Litwin CM, Johnson JM, Martins TB. 2004. The Bartonella henselae sucB gene encodes a dihydrolipoamide succinyltransferase protein reactive with sera from patients with cat-scratch disease. J Med Microbiol 53:12211227.[CrossRef].[PubMed]
25. Caponetti GC, Pantanowitz L, Marconi S, Havens JM, Lamps LW, Otis CN. 2009. Evaluation of immunohistochemistry in identifying Bartonella henselae in cat-scratch disease. Am J Clin Path 131:250256.[CrossRef].[PubMed]
26. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS. 1990. The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N Engl J Med 323:15731580.[CrossRef].[PubMed]
27. Anderson B, Kelly C, Threlkel R, Edwards K. 1993. Detection of Rochalimaea henselae in cat-scratch disease skin test antigens. J Infect Dis 168:10341036.[PubMed].[CrossRef]
28. Duncan AW, Maggi RG, Breitschwerdt EB. 2007. A combined approach for the enhanced detection and isolation of Bartonella species in dog blood samples: pre-enrichment liquid culture followed by PCR and subculture onto agar plates. J Microbiol Methods 69:273281.[CrossRef].[PubMed]
29. Dauga C, Miras I, Grimont PA. 1996. Identification of Bartonella henselae and B. quintana 16s rDNA sequences by branch-, genus- and species-specific amplification. J Med Microbiol 45:192199.[CrossRef].[PubMed]
30. Kosoy M, Hayman DT, Chan KS. 2012. Bartonella bacteria in nature: where does population variability end and a species start? Infect Genet Evol 12:894904.
31. Anderson B, Sims K, Regnery R, Robinson L, Schmidt MJ, Goral S, Hager C, Edwards K. 1994. Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR. J Clin Microbiol 32:942948.[PubMed]
32. Colborn JM, Kosoy MY, Motin VL, Telepnev MV, Valbuena G, Myint KS, Fofanov Y, Putonti C, Feng C, Peruski L. 2010. Improved detection of Bartonella DNA in mammalian hosts and arthropod vectors by real-time PCR using the NADH dehydrogenase gamma subunit (nuoG). J Clin Microbiol 48:46304633.[CrossRef].[PubMed]
33. Renesto P, Gautheret D, Drancourt M, Raoult D. 2000. Determination of the rpoB gene sequences of Bartonella henselae and Bartonella quintana for phylogenic analysis. Res Microbiol 151:831836.[PubMed].[CrossRef]
34. Rolain JM, Franc M, Davoust B, Raoult D. 2003. Molecular detection of Bartonella quintana, B. koehlerae, B. henselae, B. clarridgeiae, Rickettsia felis, and Wolbachia pipientis in cat fleas, France. Emerg Infect Dis 9:338342.[CrossRef].[PubMed]
35. Birtles RJ, Hazel S, Bown K, Raoult D, Begon M, Bennett M. 2000. Subtyping of uncultured bartonellae using sequence comparison of 16 S/23 S rRNA intergenic spacer regions amplified directly from infected blood. Mol Cell Probes 14:7987.[CrossRef].[PubMed]
36. Diaz MH, Bai Y, Malania L, Winchell JM, Kosoy MY. 2012. Development of a novel genus-specific real-time PCR assay for detection and differentiation of Bartonella species and genotypes J Clin Microbiol 50:16451649.[CrossRef].[PubMed]
37. Liberto MC, Lamberti AG, Marascio N, Matera G, Quirino A, Quirino A, Barreca GS, Baudi F, Focà A. 2011. Molecular identification of Bartonella quintana infection using species-specific real-time PCR targeting transcriptional regulatory protein (bqtR) gene. Mol Cell Probes 25:238242.[CrossRef].[PubMed]
38. Buss SN, Gebhardt LL, Musser KA. 2012. Real-time PCR and pyrosequencing for differentiation of medically relevant Bartonella species. J Microbiol Methods 91:252256.[CrossRef].[PubMed]
39. Al Dahouk S, Nockler K. 2011. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther 9:833845.[CrossRef].[PubMed]
40. Araj GF,. 2011. Brucella, p 863872. In Jorgensen JH, Pfaller MA (ed.), Manual of Clinical Microbiology, 11th ed. ASM Press, Washington, DC.
41. Serre A,. 1989. Immunology and pathophysiology of human brucellosis, p 8595. In Young EJ, Corbel MJ (ed), Brucellosis: Clinical and Laboratory Aspects. CDC Press, Boca Raton, FL.
42. Centers for Disease Control and Prevention. 1997. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 46:155.[PubMed]
43. Araj GF. 2010. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents 36:S1217.[CrossRef].[PubMed]
44. Rose JE, Roepke MH. 1957. An acidified antigen for detection of nonspecific reactions in the plate-agglutination test for bovine brucellosis. Am J Vet Res 18:550555.[PubMed]
45. Diaz R, Casanova A, Ariza J, Moriyon I. 2011. The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLoS Negl Trop Dis 5:e950.[CrossRef].[PubMed]
46. Corbel MJ. 2006. Brucellosis in humans and animals. Food and Agriculture Organization of the United Nations, World Organisation for Animal Health, and World Health Organization. http://www.who.int/csr/resources/publications/Brucellosis.pdf. (Accessed October 17, 2015).
47. Araj GF, Kattar MM, Fattouh LG, Bajakian KO, Kobeissi SA. 2005. Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis. Clin Diagn Lab Immunol 12:13341335.[CrossRef].[PubMed]
48. Centers for Disease Control and Prevention. 2008. Public health consequences of a false-positive laboratory test result for Brucella—Florida, Georgia, and Michigan, 2005. MMWR Morb Mortal Wkly Rep 57:603605.[PubMed]
49. Welch RJ, Litwin CM. 2010. A comparison of Brucella IgG and IgM ELISA assays with agglutination methodology. J Clin Lab Anal 24:160162.[CrossRef].[PubMed]
50. Coombs RR, Mourant AE, Race RR. 1945. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol 26:255266.[PubMed]
51. Díaz R, Moriyon I,. 1989. Laboratory techniques in the diagnosis of human brucellosis, p 7679. In Young EJ, Corbel MJ (ed), Brucellosis: Clinical and Laboratory Aspects. CRC Press, Boca Raton, FL.
52. Orduna A, Almaraz A, Prado A, Gutierrez MP, Garcia-Pascual A, Dueñas A, Cuervo M, Abad R, Hernández B, Lorenzo B, Bratos MA, Torres AR. 2000. Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol 38:40004005.[PubMed]
53. Casanova A, Ariza J, Rubio M, Masuet C, Diaz R. 2009. BrucellaCapt versus classical tests in the serological diagnosis and management of human brucellosis. Clin Vaccine Immunol 16:844851.[CrossRef].[PubMed]
54. Zygmunt MS, Jacques I, Bernardet N, Cloeckaert A. 2012. Lipopolysaccharide heterogeneity in the atypical group of novel emerging Brucella species. Clin Vaccine Immunol 19:13701373.[CrossRef].[PubMed]
55. Centers for Disease Control and Prevention. 2012. Brucellosis: Serology. www.cdc.gov/brucellosis/clinicians/serology.html. (Accessed October 17, 2015.)
56. Morse EV, Ristic M, Robertstad GW, Schneider DW. 1953. Cross-agglutination reactions among Brucella, Vibrio, and other microorganisms. Am J Vet Res 14:324327.[PubMed]
57. Tomaso H, Kattar M, Eickhoff M, Wernery U, Al Dahouk S, Straube E, Neubauer H, Scholz HC. 2010. Comparison of commercial DNA preparation kits for the detection of Brucellae in tissue using quantitative real-time PCR. BMC Infect Dis 10:100.[CrossRef].[PubMed]
58. Maas KS, Mendez M, Zavaleta M, Manrique J, Franco MP, Mulder M, Bonifacio N, Castañeda ML, Chacaltana J, Yagui E, Gilman RH, Guillen A, Blazes DL, Espinosa B, Hall E, Abdoel TH, Smits HL. 2007. Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up. Am J Trop Med Hyg 76:698702.[PubMed]
59. Sato T, Fujita H, Ohara Y, Homma M. 1990. Microagglutination test for early and specific serodiagnosis of tularemia. J Clin Microbiol 28:23722374.[PubMed]
60. Carlsson HE, Lindberg AA, Lindberg G, Hederstedt B, Karlsson KA, Agell BO. 1979. Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia. J Clin Microbiol 10:615621.[PubMed]
61. Sharma N, Hotta A, Yamamoto Y, Fujita O, Uda A, Fujita O, Uda A, Morikawa S, Yamada A, Tanabayashi K. 2013. Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay. Clin Vaccine Immunol 20:916.[CrossRef].[PubMed]
62. Nuti DE, Crump RB, Dwi Handayani F, Chantratita N, Peacock SJ, Bowen R, Felgner PL, Davies DH, Wu T, Lyons CR, Brett PJ, Burtnick MN, Kozel TR, AuCoin DP. 2011. Identification of circulating bacterial antigens by in vivo microbial antigen discovery. MBio 16:2.
63. Kilic S, Celebi B, Yesilyurt M. 2012. Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia. Diagn Microbiol Infect Dis 74:15.[CrossRef].[PubMed]
64. Brett M, Doppalapudi A, Respicio-Kingry LB, Myers D, Husband B, Pollard K, Mead P, Petersen JM, Whitener CJ. 2012. Francisella novicida bacteremia after a near-drowning accident. J Clin Microbiol 50:28262829.[CrossRef].[PubMed]
65. Kugeler KJ, Mead PS, McGowan KL, Burnham JM, Hogarty MD, Ruchelli E, Pollard K, Husband B, Conley C, Rivera T, Kelesidis T, Lee WM, Mabey W, Winchell JM, Stang HL, Staples JE, Chalcraft LJ, Petersen JM. 2008. Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood. J Clin Microbiol 46:24282431.[CrossRef].[PubMed]
66. Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA. 2004. Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol 17:489495.[CrossRef].[PubMed]
67. Molins CR, Carlson JK, Coombs J, Petersen JM. 2009. Identification of Francisella tularensis subsp. tularensis A1 and A2 infections by real-time polymerase chain reaction. Diagn Microbiol Infect Dis 64:612.[CrossRef].[PubMed]
68. Junhui Z, Ruifu Y, Jianchun L, Songle Z, Meiling C, Fengxiang C, Hong C. 1996. Detection of Francisella tularensis by the polymerase chain reaction. J Med Microbiol 45:477482.[CrossRef].[PubMed]
69. Kantardjiev T, Padeshki P, Ivanov IN. 2007. Diagnostic approaches for oculoglandular tularemia: advantages of PCR. Br J Ophthalmol 91:12061208.[CrossRef].[PubMed]
70. Kuroda M, Sekizuka T, Shinya F, Takeuchi F, Kanno T, Sata T, Asano S. 2012. Detection of a possible bioterrorism agent, Francisella sp., in a clinical specimen by use of next-generation direct DNA sequencing. J Clin Microbiol 50:18101812.[CrossRef].[PubMed]

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error